Pilot of a colorectal cancer education program
Official title: Pilot Testing of a Colorectal Cancer Education Program
Run by NYU Langone Health · NCT07361614 · Data updated 2026-11-12
This program will test whether a culturally and language‑targeted education program helps adults aged 45–75 who are overdue for colorectal cancer screening complete recommended screening.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 75 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | February 5, 2026 |
| Main results expected | February 1, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | April 29, 2026 |
| Trial ID | NCT07361614 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 45–75 years old who are overdue for CRC screening (no recent stool test and no recent colonoscopy/sigmoidoscopy/CT colonography), speak English or Chinese, and can provide consent, without a history of colorectal cancer or colectomy.
✕Probably not a fit
Patients already guideline‑concordant for CRC screening, those with a history of colorectal cancer or colectomy, or those who do not understand English or Chinese are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a pilot interventional program delivering culturally and linguistically tailored colorectal cancer education to adults aged 45–75 who are not up to date with screening. Participants who speak English or Chinese will receive targeted educational materials and outreach at NYU Langone Health, with follow-up to document screening completion. The primary aims are to measure feasibility, acceptability, and preliminary effectiveness in increasing screening completion. Results will inform larger trials or implementation efforts if promising.
Why it matters
Potential benefit: If successful, the program could increase colorectal cancer screening completion among overdue patients, leading to earlier detection and better outcomes.
How similar studies have gone: Prior trials of culturally tailored education and navigation interventions have increased colorectal cancer screening rates in some populations, though results vary and larger studies are still needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 45-75 years 2. Not guideline concordant (no stool testing for CRC within past 1 year) 3. No colonoscopy in past 10 years; no sigmoidoscopy or CT colonography in past 5 years) 4. Understands English or Chinese languages. 5. Willing and able to consent to participate Exclusion Criteria: 1\) history of CRC or colectomy
Where it's running
-
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Suzanne Vang — NYU Langone Health
- Study coordinator: Angel Mui
- Email: Angel.mui@nyulangone.org
- Phone: 646-501-3521
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Electrolyte beverage plus PEG for colonoscopy bowel prep
This randomized trial tests different mixes of electrolyte drink and water with PEG to see which bowel prep regimen gives the best cleansing for adults getting colonoscopy.
-
Using prior CT scans to guide colonoscope insertion
This trial will test whether using a patient's existing abdominal/pelvic CT scan to guide colonoscope insertion makes colonoscopy faster and more comfortable for adults having screening or diagnostic colonoscopy.
-
Animated storytelling video to boost colorectal cancer screening
A short animated video is being tested to see if it makes adults in the U.S. who haven’t been screened more likely to plan getting screened for colorectal cancer.
-
Does GP endorsement and early information improve colonoscopy follow-up after a positive colorectal cancer screening test?
This study tests whether giving patients early information about colonoscopy and having their GP endorse the follow-up can increase how many people in France get a colonoscopy within six months after a positive screening result.
-
Noninvasive blood miRNA test to screen for multiple gastrointestinal cancers.
This project will test whether a blood-based microRNA panel can detect several types of gastrointestinal cancer in adults using stored blood samples.
-
Cleansing options to improve colonoscopy tolerance
This test compares low-volume tablet bowel preps (Sutab/Suflave) with standard Golytely for adults having outpatient colonoscopies to see which is better tolerated and preferred.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.